miR-200a, 200b, 200c, 141 |
Bladder cancer |
[29] |
miR-200a, 200b, 200c, 141, 429 |
Breast cancer |
[30-32] |
miR-200a, 200b, 200c |
Colorectal cancer |
[33; 34; 58] |
miR-200a, 200c |
Cutaneous melanoma |
[35] |
miR-200a, 200b, 200c, 141, 429 |
Endometrial cancer |
[36; 37] |
miR-200a, 200b, 200c, 141 |
Gastric cancer |
[38-41] |
miR- 200c |
Hepatocellular tumor |
[42] |
miR-200a, 200b, 200c, 141, 429 |
Lung cancer |
[43; 59] |
miR-200a |
Nasopharyngeal carcinoma |
[44] |
miR-200a, 200b, 200c, 141, 429 |
Oral squamous cell carcinoma |
[45] |
miR-200a, 200b, 200c, 141, 429 |
Ovarian cancer |
[46-51] |
miR-200a, 200b |
Pancreatic cancer |
[52; 60] |
miR-200b, 200c, 141, 429 |
Pleural mesothelioma |
[53] |
miR-200a |
Prostate cancer |
[54] |
miR-200a, 200b, 200c, 141 |
Renal cell carcinoma |
[55] |
miR-200a, 200c, 141, 429 |
Spindle cell carcinoma of the head and neck |
[56] |
miR-200a, 200b, 200c, 141 |
Thyroid carcinoma |
[57] |